Product Description
The Brazilian dental implant and final abutment market was valued at $316 million in 2024. This is expected to increase over the forecast period at a CAGR of 13.6% to reach over $770 million.
The full report suite on the Brazilian market for dental implants and final abutments includes dental implants, final abutments, instrument kits, treatment planning software and surgical guides.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
BRAZIL DENTAL IMPLANTS MARKET TRENDS

The cost-sensitive nature of the market significantly hinders the growth potential of the dental implant and final abutment segments. In Brazil, numerous local, low-cost brands operate with minimal investment in marketing and research and development compared to major international implant manufacturers. This enables them to offer aggressive price cuts while remaining profitable. Implants from leading international companies are typically sold at a premium due to strong brand recognition, but their market share remains limited, as relatively few dentists or patients are willing – or able – to pay these higher prices. Straumann Group stands as a notable exception, having secured a substantial portion of the Brazilian implant market. In response to growing competition from affordable local brands, even large multinational corporations have resorted to price reductions to stay competitive.
Brazil Dental Implants Market Share Insights

- Straumann Group was the strongest competitor in the dental implant and final abutment markets in 2024. In addition, it placed third in the treatment planning software and guided surgery markets. Straumann dominates the premium dental implant market, while its subsidiary, Neodent, dominates the value dental implant market. With a reputation for high-quality dental implant solutions and a comprehensive product portfolio, Straumann has gained the trust of dental professionals and patients alike. Straumann is well positioned to continue performing as a market leader in the dental implant industry. A continuous emphasis on mergers and acquisitions has greatly strengthened the company profile.
- Envista is the parent company of Nobel Biocare, Implant Direct, KaVo Kerr, Alpha-Bio Tech and other dental equipment and consumables brands. It was the second-leading competitor in the overall Brazilian dental implant and final abutment market in 2024. In 2019, Danaher announced that its dental division, including Nobel Biocare and Implant Direct, would be split off from the company to form an independent publicly traded company known as Envista. Envista went public in late 2019 on the New York Stock Exchange (NYSE), under the ticker NVST, and used the funds raised in its initial public offering (IPO) to purchase its constituent companies from Danaher, completing the separation of the two companies. Envista is now a fully independent public company. According to the company’s Q4 2024 report, its core sales had a 2.0% growth when compared to Q4 2023. The company reported improved performance in implants business across Nobel Biocare, Implant Direct and Alpha-Bio brands. Spark aligners showed continued market share gains and gross margin improvement.
- Dentsply Sirona was the third-leading competitor of the overall dental implant and final abutment market in Brazil in 2024. The company’s implant portfolio includes well-established systems such as ANKYLOS®, MIS®, the Astra Tech Implant System EV, DS PrimeTaper and the Atlantis line of custom abutments, offering solutions designed to support both conventional and digital workflows. In Brazil, the company is mostly known for its ANKYLOS® product line, which is considered a premium product. Dentsply Sirona was the third-leading competitor in the premium dental implant market, competing directly with Envista, the parent company of Nobel Biocare, and Straumann Group.
MARKET SEGMENTATION SUMMARY
- Dental Implant – Further Segmented Into:
- Type: Premium, Value, Discount, and Mini.
- Shape: Parallel Wall, Tapered
- Material: Titanium, Ceramic/Zirconia
- Procedure Type: One-Stage Surgery, Two-Stage Surgery, Immediate Loading
- Connection Type: Internal Connection, External Connection, One-Piece
- Application: Single-Tooth Replacement, Multi-Tooth Bridge Partial Arch Securement, Multi-Tooth Bridge Full Arch Securement, Dental Securement
- Final Abutment – Further Segmented Into:
- Fabrication: Stock, Custom Cast, CAD/CAM
- Material: Titanium, Ceramic/Zirconia, Gold
- Type: Cement-Retained, Screw-Retained, Denture Retaining
- Instrument Kit
- Treatment Planning Software
- Surgical Guide – Further Segmented Into:
- Type: Traditional Manufacturer, Third Party, In-House
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | Brazil |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.